皇家华人

header-logo
Research Lab Bench
Physiology

Welcome to the Nakagawa Lab

The Nakagawa lab combines tools from neuroscience and physiology to understand the fundamental mechanisms of neural and autonomic mechanisms of cardiovascular control and how dysregulation of these systems contributes to the development of cardiovascular diseases. 
Nakagawa Lab_2024 Team Photo

Our Mission

Our mission is to support the future generation of outstanding scientists by creating an optimal environment for personal, scientific, and professional growth.
Our laboratory focuses on understanding the neural mechanisms of blood pressure and autonomic control that can be involved in the development and progression of hypertension. The brain renin-angiotensin system (RAS) plays a key role in blood pressure regulation, water & salt intake, metabolic function & cognitive function. Thus, we aim to understand the mechanisms contributing to brain RAS dysfunction and to address the neural bases of hypertension.
To study this, we utilize 1) genetically engineered models to manipulate expression of key genes in the brain, 2) induce expression of fluorescent reporter genes or genetically encoded biosensors to label & trace distinct proteins and cells in the brain, 3) methods to study the activity of neuronal circuits, and 4) methods to activate and suppress these circuits such as optogenetics and chemogenetics. State-of-the-art radiotelemetric devices are implanted in these mice to monitor cardiovascular function 24/7 wirelessly.

Current Projects

Nakagawa Lab_Hypertension_Image Text Split

Hypertension: The Silent Killer

Despite significant progress, cardiovascular (CV) diseases are still the leading cause of death globally. One of the main risk factors for CV disease is elevated blood pressure (BP) or hypertension (HT). High BP is typically managed with a wide variety of drugs. However, a vast number of patients with HT do not achieve desirable BP with conventional therapeutic options. Notably, patients who exhibit resistant HT are associated with autonomic imbalance and therefore, novel strategies to ameliorate sympathoexcitation and restore the depressed vagal parasympathetic tone (renal nerve ablation, vagus nerve stimulation, carotid baroreflex therapy, acetylcholinesterase inhibitors, etc.) are now recognized as potential therapeutic options for diseases beyond HT.

Thus, our laboratory’s main focus is to understand the fundamental neural mechanisms that control BP and the autonomic nervous system. We believe that our findings might contribute to developing new alternative therapies to treat HT.

 

(Fig. 1 - right)

Nakagawa_The Brain RAS_Image Text Split

The Brain RAS: A Fundamental Mechanism of Blood Pressure Control

The renin-angiotensin system (RAS) is one of the most important mechanisms of BP control and fluid and electrolyte homeostasis. As shown in Figure 2, the activation of the RAS requires a two-step enzymatic process to generate Angiotensin II, an octapeptide that exerts potent pressor effects through angiotensin type 1 receptors (AT1R)-mediated mechanism. Importantly, renin plays a critical role in the regulation of the RAS since it is the rate-limiting enzyme of this biosynthetic cascade. Besides the classical RAS found in the circulating system, the existence of an unconventional RAS that operates locally in specific tissues, such as the brain, has been proposed.

Although the critical role of the local activation of the RAS in the brain to control BP regulation, hydromineral balance, autonomic function, and metabolism is well accepted it remains unclear how and where angiotensin (ANG)-II, the main bioactive component of the RAS, is generated within the brain; Surprisingly, whether renin, the rate-limiting enzyme of ANG-II biosynthesis, is expressed and necessary for the cleavage of angiotensinogen (AGT) to generate ANG-I in the brain remains controversial.

(Fig. 2 - left)

Unraveling a Scientific Mystery That Has Persisted for 5 Decades: the Discovery of Renin-Expressing Neurons in the Nucleus Ambiguus

Nakagawa Lab_NuAm_Research Photo
For many years, conventional techniques that are normally used to detect the abundant amounts of renin in plasma and kidneys have been used in an attempt to detect renin in whole brain tissue homogenates. But these methods lack sensitivity, specificity, and especially the anatomical precision to detect neurons that produce extremely low amounts of renin. Thus, these questionable reports raised a misconception that renin is not expressed in the brain. Our team has mastered key technology from neuroscience and acquired expertise in neuroanatomy to address this important question with the appropriate tools and techniques. These advanced techniques and new knowledge helped us to obtain convincing evidence for the expression of renin in cholinergic neurons within the brainstem, specifically, the nucleus ambiguus (NuAm), which is a relatively understudied brainstem region in the field of hypertension (Fig. 3).

This exciting discovery is critical since the existence of a select population of neurons expressing renin incorporates new evidence that ANG might operate as a neurotransmitter in the brain. There are two main theories about this topic: a) the volume transmission hypothesis where ANG peptides are generated in the extracellular space acting as neurohormones, and b) the wiring transmission hypothesis where ANG generated by neurons acts as a neurotransmitter itself. Although several studies support the second possibility, the lack of evidence that renin is expressed in neurons has been the major limitation in defining ANG as a neurotransmitter. Thus, the identification of the renin-neurons in the NuAm could be an important finding to solve this critical question. Cellular, molecular, and neurobiological characterization of renin-expressing neurons will provide key information to understand how the RAS operates in the brain and ensure definitive evidence of the functional role of renin in the brain.

 

(Fig. 3)

New Advances: Characterizing the Novel Renin-Expressing Neurons Using State-of-the-Art Technology

Current studies are designed to understand the physiological role of the novel population of neurons that expresses renin in the NuAm. Since the laboratory was established at MCW in 2022, we have progressively advanced in our technical repertory to target genes with superior selectivity and neuroanatomical precision. We also incorporated new techniques to detect transcriptomic data in brain sections with high fidelity. Currently, we are conducting stereotactic microinjections and using conditional knockout mice to genetically ablate renin from the NuAm or cholinergic neurons (Fig. 4). These new techniques will allow us to define the function of renin in these cells. New mouse models carrying renin-reported genes are now available to map the entire brain for renin-expressing cells. These mice, which express a red fluorescent protein TdTomato in renin cells, were crossed with AT1R reporter mice, where green fluorescent protein expression is controlled by AT1R promoter. These triple transgenic mice will allow us to identify cells producing ANG II (renin) and cells responding to ANG II (AT1R) simultaneously and assess the anatomical proximity between them (Fig. 5). Retrograde and anterograde tracing studies revealed that neurons expressing renin in the NuAm extend projections to the cardiac ganglion suggesting that renin-expressing neurons could be cardiomodulatory. Considerable effort is currently invested in developing optogenetic and chemogenetic tools to modulate neural activity of renin-expressing neurons using either DREADDs (chemogenetics) or light (optogenetics). These tools will provide critical information about the physiological role of these novel neuronal populations. To study neuronal activity in awake animals, we recently acquired an in vivo calcium imaging system (miniscope) and mice carrying genetically encoded calcium sensors (GCaMP). These will allow us to identify what kind of external stimuli activate renin-expressing neurons. Finally, we aim to understand the cellular identity and transcriptomic profile of these neurons. In addition to bulk and single-cell RNA sequencing, we recently acquired spatial transcriptomics (10x Xenium), which will allow us to profile renin-expressing neurons in the NuAm and other brain regions.
Nakagawa Lab_NuAm
(Fig. 4)
Nakagawa Lab_AT1R-eGFP

(Fig. 5)

Meet Our Team

headshot

Pablo Nakagawa, PhD

Assistant Professor

headshot

Eva Fekete, PhD

Research Scientist

headshot

Mina Ghobrial

G2 Student

headshot

Ana Hantke Guixa, BS

Research Technologist I

headshot

Katie Kaminski

Graduate Student

headshot

Haruka Okabe, MS

Research Technologist I

Publications

  • (Mathieu NM, Tan EE, Reho JJ, Brozoski DT, Muskus PC, Lu KT, Wackman KK, Grobe JL, Nakagawa P, Sigmund CD.) Hypertension. 2024 Jun;81(6):1332-1344 PMID: 38629290 PMCID: PMC11096025 SCOPUS ID: 2-s2.0-85193429264 04/17/2024

  • (Reho JJ, Muskus PC, Bennett DM, Grobe CC, Burnett CML, Nakagawa P, Segar JL, Sigmund CD, Grobe JL.) Am J Physiol Regul Integr Comp Physiol. 2024 Mar 01;326(3):R242-R253 PMID: 38284128 PMCID: PMC11213288 SCOPUS ID: 2-s2.0-85186271298 01/29/2024

  • (Mathieu NM, Nakagawa P, Grobe JL, Sigmund CD.) Hypertension. 2024 Jan;81(1):6-16 PMID: 37449411 PMCID: PMC10787814 SCOPUS ID: 2-s2.0-85180800778 07/14/2023

  • (Ziegler AA, Lawton SBR, Grobe CC, Reho JJ, Freudinger BP, Burnett CML, Nakagawa P, Grobe JL, Segar JL.) Am J Physiol Regul Integr Comp Physiol. 2023 Nov 01;325(5):R576-R592 PMID: 37720996 PMCID: PMC10866575 SCOPUS ID: 2-s2.0-85174752582 09/18/2023

  • (Grobe CC, Reho JJ, Brown-Williams D, Ziegler AA, Mathieu NM, Lawton SBR, Fekete EM, Brozoski DT, Wackman KK, Burnett CML, Nakagawa P, Sigmund CD, Segar JL, Grobe JL.) Hypertension. 2023 Sep;80(9):1871-1880 PMID: 37470185 PMCID: PMC10528934 SCOPUS ID: 2-s2.0-85168254483 07/20/2023

  • (Balapattabi K, Yavuz Y, Jiang J, Deng G, Mathieu NM, Ritter ML, Opichka MA, Reho JJ, McCorvy JD, Nakagawa P, Morselli LL, Mouradian GC Jr, Atasoy D, Cui H, Hodges MR, Sigmund CD, Grobe JL.) Cell Rep. 2023 Aug 29;42(8):112935 PMID: 37540598 PMCID: PMC10530419 SCOPUS ID: 2-s2.0-85169503465 08/04/2023

  • (Mathieu NM, Fekete EM, Muskus PC, Brozoski DT, Lu KT, Wackman KK, Gomez J, Fang S, Reho JJ, Grobe CC, Vazirabad I, Mouradian GC Jr, Hodges MR, Segar JL, Grobe JL, Sigmund CD, Nakagawa P.) Function (Oxf). 2023;4(5):zqad043 PMID: 37609445 PMCID: PMC10440998 SCOPUS ID: 2-s2.0-85168790693 08/23/2023

  • (Wagner VA, Deng G, Claflin KE, Ritter ML, Cui H, Nakagawa P, Sigmund CD, Morselli LL, Grobe JL, Kwitek AE.) Front Cell Neurosci. 2023;17:1207350 PMID: 37293629 PMCID: PMC10244568 SCOPUS ID: 2-s2.0-85161193387 06/09/2023

  • (Ritter ML, Deng G, Reho JJ, Deng Y, Sapouckey SA, Opichka MA, Balapattabi K, Wackman KK, Brozoski DT, Lu KT, Paradee WJ, Gibson-Corley KN, Cui H, Nakagawa P, Morselli LL, Sigmund CD, Grobe JL.) Hypertension. 2022 Dec;79(12):2843-2853 PMID: 36259376 PMCID: PMC9649888 SCOPUS ID: 2-s2.0-85141891708 10/20/2022

  • (Mathieu NM, Nakagawa P, Grobe CC, Reho JJ, Brozoski DT, Lu KT, Wackman KK, Ritter ML, Segar JL, Grobe JL, Sigmund CD.) Hypertension. 2022 Nov;79(11):2480-2492 PMID: 36215165 PMCID: PMC9669141 SCOPUS ID: 2-s2.0-85140375825 10/11/2022

  • (Oliveira V, Reho JJ, Balapattabi K, Ritter ML, Mathieu NM, Opichka MA, Lu KT, Grobe CC, Silva SD Jr, Wackman KK, Nakagawa P, Segar JL, Sigmund CD, Grobe JL.) Am J Physiol Regul Integr Comp Physiol. 2022 Oct 01;323(4):R410-R421 PMID: 35816717 PMCID: PMC9512112 SCOPUS ID: 2-s2.0-85138457982 07/12/2022

  • (Mouradian GC Jr, Liu P, Nakagawa P, Duffy E, Gomez Vargas J, Balapattabi K, Grobe JL, Sigmund CD, Hodges MR.) Front Synaptic Neurosci. 2022;14:910820 PMID: 35844900 PMCID: PMC9280690 SCOPUS ID: 2-s2.0-85134237459 07/19/2022

Publications of from the

Nakagawa Lab Image Gallery

1 /
Stephanie Watts Career Development Award Finalist

Stephanie Watts Career Development Award Finalist

Hide Caption
Mina Ghobrial at The 2023 Cardiovascular Center Research Retreat

Mina Ghobrial at The 2023 Cardiovascular Center Research Retreat

Hide Caption
Nakagawa Lab_2024 AHA Hypertension Scientific Sessions Team Photo

2024 AHA Hypertension Scientific Sessions Team Photo

Hide Caption
Nakagawa Lab_2024 Team Photo

2024 Team Photo

Hide Caption
Nakagawa LabAzeez Ganiyu And Cotes Royson 2024 Aspire Program Students

Azeez Ganiyu and Cotes Royson - 2024 ASPIRE Program Students

Hide Caption

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.